Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Accumulated Expenses: 2023-2024

Historic Accumulated Expenses for Neurogene (NGNE) over the last 2 years, with Dec 2024 value amounting to $9.7 million.

  • Neurogene's Accumulated Expenses fell 9.71% to $9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.4 million, marking a year-over-year decrease of 9.71%. This contributed to the annual value of $9.7 million for FY2024, which is 44.38% down from last year.
  • Neurogene's Accumulated Expenses amounted to $9.7 million in FY2024, which was down 44.38% from $17.5 million recorded in FY2023.
  • In the past 5 years, Neurogene's Accumulated Expenses ranged from a high of $17.5 million in FY2023 and a low of $9.7 million during FY2024.
  • In the last 2 years, Neurogene's Accumulated Expenses had a median value of $13.6 million in 2023 and averaged $13.6 million.
  • Data for Neurogene's Accumulated Expenses shows a maximum YoY tumbled of 44.38% (in 2024) over the last 5 years.
  • Neurogene's Accumulated Expenses (Yearly) stood at $17.5 million in 2023, then crashed by 44.38% to $9.7 million in 2024.